Product NDC: | 57664-633 |
Proprietary Name: | MIDAZOLAM |
Non Proprietary Name: | MIDAZOLAM HYDROCHLORIDE |
Active Ingredient(s): | 1 mg/mL & nbsp; MIDAZOLAM HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57664-633 |
Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090696 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120808 |
Package NDC: | 57664-633-43 |
Package Description: | 10 VIAL in 1 CARTON (57664-633-43) > 2 mL in 1 VIAL (57664-633-40) |
NDC Code | 57664-633-43 |
Proprietary Name | MIDAZOLAM |
Package Description | 10 VIAL in 1 CARTON (57664-633-43) > 2 mL in 1 VIAL (57664-633-40) |
Product NDC | 57664-633 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MIDAZOLAM HYDROCHLORIDE |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20120808 |
Marketing Category Name | ANDA |
Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
Substance Name | MIDAZOLAM HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |